An official website of the United States government
TABLE 10. Estimated percent using inhaled short acting beta agonists among adults1 with current2 or active3 asthma status by state/territory – BRFSS Asthma Call-back Survey, United States, 2010
| State/Territory | Current | Active | ||||||
|---|---|---|---|---|---|---|---|---|
| Sample size± |
% | SE§ | 95% CI† | Sample size |
% | SE | 95% CI | |
| Alabama | 302 | 56.2 | 4.1 | (48.2 – 64.2) | 317 | 54.8 | 4.2 | (46.6 – 63.0) |
| Arizona | 273 | 38.8 | 6.0 | (27.0 – 50.6) | 283 | 39.7 | 6.0 | (27.9 – 51.5) |
| California | 502 | 54.2 | 3.2 | (47.9 – 60.5) | 545 | 50.3 | 3.1 | (44.2 – 56.4) |
| Connecticut | 250 | 59.1 | 5.2 | (48.9 – 69.3) | 283 | 55.1 | 4.7 | (45.9 – 64.3) |
| District of Columbia | 134 | 53.3 | 5.8 | (41.9 – 64.7) | 151 | 51.2 | 5.5 | (40.4 – 62.0) |
| Florida | 414 | 47.7 | 4.9 | (38.1 – 57.3) | 449 | 45.9 | 4.9 | (36.3 – 55.5) |
| Georgia | 171 | 48.1 | 5.7 | (36.9 – 59.3) | 176 | 50.6 | 5.6 | (39.6 – 61.6) |
| Hawaii | 271 | 54.3 | 5.0 | (44.5 – 64.1) | 287 | 56.5 | 4.5 | (47.7 – 65.3) |
| Illinois | 166 | 66.9 | 5.5 | (56.1 – 77.7) | 173 | 64.5 | 5.4 | (53.9 – 75.1) |
| Indiana | 482 | 53.0 | 3.5 | (46.1 – 59.9) | 508 | 53.5 | 3.4 | (46.8 – 60.2) |
| Iowa | 261 | 48.4 | 4.5 | (39.6 – 57.2) | 270 | 45.6 | 4.4 | (37.0 – 54.2) |
| Kansas | 426 | 54.6 | 4.1 | (46.6 – 62.6) | 442 | 52.7 | 4.1 | (44.7 – 60.7) |
| Louisiana | 187 | 46.2 | 7.4 | (31.7 – 60.7) | 203 | 47.5 | 7.0 | (33.8 – 61.2) |
| Maine | 466 | 53.9 | 3.5 | (47.0 – 60.8) | 486 | 54.4 | 3.4 | (47.7 – 61.1) |
| Maryland | 256 | 43.3 | 5.8 | (31.9 – 54.7) | 284 | 42.3 | 5.6 | (31.3 – 53.3) |
| Massachusetts | 220 | 40.1 | 5.6 | (29.1 – 51.1) | 231 | 42.3 | 5.6 | (31.3 – 53.3) |
| Michigan | 540 | 56.5 | 3.4 | (49.8 – 63.2) | 573 | 54.3 | 3.3 | (47.8 – 60.8) |
| Mississippi | 330 | 51.1 | 4.4 | (42.5 – 59.7) | 339 | 49.1 | 4.2 | (40.9 – 57.3) |
| Missouri | 265 | 61.1 | 5.1 | (51.1 – 71.1) | 280 | 57.4 | 4.9 | (47.8 – 67.0) |
| Montana | 326 | 56.6 | 4.9 | (47.0 – 66.2) | 339 | 54.9 | 4.7 | (45.7 – 64.1) |
| Nebraska | 607 | 45.9 | 4.7 | (36.7 – 55.1) | 633 | 47.7 | 3.9 | (40.1 – 55.3) |
| Nevada | 143 | 57.7 | 6.5 | (45.0 – 70.4) | 168 | 49.9 | 6.2 | (37.7 – 62.1) |
| New Hampshire | 283 | 57.7 | 4.6 | (48.7 – 66.7) | 306 | 56.7 | 4.4 | (48.1 – 65.3) |
| New Jersey | 346 | 35.4 | 4.3 | (27.0 – 43.8) | 377 | 31.2 | 3.7 | (23.9 – 38.5) |
| New Mexico | 333 | 55.8 | 4.9 | (46.2 – 65.4) | 351 | 55.5 | 4.6 | (46.5 – 64.5) |
| New York | 133 | 51.8 | 6.0 | (40.0 – 63.6) | 145 | 52.4 | 5.7 | (41.2 – 63.6) |
| North Dakota | 178 | 55.0 | 5.7 | (43.8 – 66.2) | 185 | 53.9 | 5.6 | (42.9 – 64.9) |
| Ohio | 357 | 40.6 | 4.2 | (32.4 – 48.8) | 382 | 39.4 | 4.1 | (31.4 – 47.4) |
| Oklahoma | 343 | 60.2 | 4.2 | (52.0 – 68.4) | 365 | 57.6 | 4.1 | (49.6 – 65.6) |
| Oregon | 208 | 48.7 | 5.9 | (37.1 – 60.3) | 234 | 45.1 | 5.6 | (34.1 – 56.1) |
| Pennsylvania | 412 | 50.8 | 3.7 | (43.5 – 58.1) | 437 | 49.5 | 3.5 | (42.6 – 56.4) |
| Rhode Island | 326 | 51.6 | 4.5 | (42.8 – 60.4) | 349 | 49.7 | 4.3 | (41.3 – 58.1) |
| Texas | 651 | 54.8 | 4.6 | (45.8 – 63.8) | 721 | 51.4 | 4.6 | (42.4 – 60.4) |
| Utah | 438 | 40.9 | 4.3 | (32.5 – 49.3) | 460 | 43.4 | 3.9 | (35.8 – 51.0) |
| Vermont | 403 | 53.3 | 3.8 | (45.9 – 60.7) | 435 | 50.9 | 3.7 | (43.6 – 58.2) |
| Washington | 676 | 49.6 | 3.2 | (43.3 – 55.9) | 706 | 50.0 | 2.9 | (44.3 – 55.7) |
| West Virginia | 205 | 58.0 | 4.8 | (48.6 – 67.4) | 203 | 58.6 | 5.1 | (48.6 – 68.6) |
| Wisconsin | 221 | 63.4 | 5.0 | (53.6 – 73.2) | 243 | 58.2 | 5.0 | (48.4 – 68.0) |
| Puerto Rico | 118 | 42.2 | 9.9 | (22.8 – 61.6) | 159 | 35.2 | 7.2 | (21.1 – 49.3) |
| 39 state total | 12,623 | 51.5 | 1.1 | (49.3 – 53.7) | 13,478 | 49.7 | 1.0 | (47.7 – 51.7) |
| Median | 53.3 | 50.9 | ||||||
| Range | 35.4-66.9 | 31.2-64.5 | ||||||
1 Aged ≥ 18 years
2 “Yes” response to “Do you still have asthma?”
3 Reported any of the following during the past year: asthma medication use, asthma symptoms, or MD visits for asthma
± Sample size excludes “DK/Refused”
§ Standard error
† Confidence interval